|105.97||+1.35 / +1.29%|
As of 12:59pm ET
|105.97||0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 115.00, with a high estimate of 144.00 and a low estimate of 93.00. The median estimate represents a +8.52% increase from the last price of 105.97.
The current consensus among 4 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.